National Biotechnology and Biomanufacturing Initiative
National Biotechnology and Biomanufacturing Initiative
From Pond to Product: The Gellan Gum Revolution!
🌊 Discover the journey of gellan gum from pond to product! 🌿 Used in food, cosmetics, and pharmaceuticals. 🚀💡 ScienceMatters
Regeneron Cuts Costs by Streamlining AAV Production!
**Excerpt:** Regeneron revolutionizes AAV manufacturing by eliminating endonuclease! 🌟 Save up to $100,000 per batch while enhancing efficiency! 💰🔬⚙️
Sana Biotechnology Launches New Facility in WA!
Sana Biotechnology celebrates a new biomanufacturing facility in Bothell, WA, boosting cell and gene therapy production! 🎉🏭🧑🔬📦🤝
Revolutionizing Bioprocessing with New Spectroscopy Technique!
**Excerpt:** 🌟 Discover how novel ATR-FTIR spectroscopy transforms upstream monitoring in bioprocessing, enhancing cell health analysis and efficiency! 📊🔍💡🛠️
Revolutionary AI Model Transforms Drug Development Confidentially!
Unlocking drug development! 🧪 New Jersey researchers built a model to estimate antibody viscosity while keeping data confidential. 🔒✨ DeepLearning
Defense Department Chooses Just – Evotec for Biomanufacturing Breakthrough
📢 The U.S. Department of Defense selects Just - Evotec Biologics for biomanufacturing optimization! 💼💲🔬✅ $39 million program to enhance rapid response capabilities.
Breaking News: Bota Bio and NHU Join Forces for High-Value Biomanufacturing
📢 Bota Bio and NHU team up in a strategic biomanufacturing partnership to produce top-quality sustainable products. 💼🌱
Fujifilm Diosynth Invests $12B in Massive NC Expansion
📢 Fujifilm Diosynth Biotechnologies invests $1.2B to expand biomanufacturing facility in NC, creating 680 new jobs. 🏭💼🌍📈
Revolutionizing Bioprocessing with Advanced Imaging
🔍 Ongoing advances in computer architecture and data analysis are revolutionizing bioprocessing, making imaging an essential tool. 🌱📊👩🔬
Revolutionizing Bioprocessing: Boost Production and Achieve Scalability
🔍 Upstream bioprocessing can be more intense and stable with holistic monitoring and control technologies. 🔬 Experts discuss platforms for industrializing cell therapy, machine-learning-assisted clone selection, microbioreactors for modeling large-scale processes, and streamlined process analytical technology. 📊 These options can boost production and achieve a state of readiness in biomanufacturing. 🚀 The goal is to have a reliable and scalable platform from the start. 🧪 Artificial intelligence can help predict clone performance in intensified processes. 🌱 Clones optimized for fed-batch processes may not be ideal for perfusion processes. ⚙️ True perfusion processes should start with clones optimized for perfusion conditions.
